Ovarian cancer, Secondary cancers
Open
Other
This study is measuring the level of a biomarker in the blood to work out early on if bevacizumab is working.
It is for women whose cancer has spread outside the pelvis or elsewhere in the body and who have:
ovarian cancer,
primary peritoneal cancer or
fallopian tube cancer
These cancers are treated in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.
Cancer Research UK supports this trial.
Recruitment start: 16 March 2021
Recruitment end: 30 September 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gordon Jayson
Cancer Research UK
University of Manchester
This is Cancer Research UK trial number CRUK/19/015.
Last reviewed: 04 Mar 2025
CRUK internal database number: 17183
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
